About PolpharmaWe are the largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market. We actively operate in the markets of Central and Eastern Europe, the Caucasus and Central Asia.
ResponsibilityBeing the largest Polish pharmaceutical company we want to help people to live a healthy life in a healthy world. Social responsibility is an integral part of the management strategy in our company.
CareerPolpharma's development is possible only thanks to the commitment of our employees as well as the involvement of students and graduates in various business areas.
We are leading regional (CEE and CIS) manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market and a part of a multinational group. For over 80 years, trusted by patients, healthcare professionals and business partners alike.
MarketsPOLAND:Polfa Warszawa S.A. (Warsaw)Polpharma (Starogard Gdański, Warsaw Duchnice, Nowa Dęba, Sieradz)Visit our Manufacturing plants to discover more.
Having balanced OTC vs Rx portfolio Strengthening the therapeutic offer to the Customer: - Ophthalmology, - Cardiology, Go to market Synergies
Being the therapeutic partner Focused on enabling customers to better serve their patients by communicating the role each brand plays and the additional services that Polpharma can provide to address the customers needs Expand successful therapeutic franchises across markets
Leverage local R&D and Manufacturing Poland: local producer status is a factor in reimbursed product price negotiation
Successful transformation Ongoing initiatives focusing on Innovation, Corporate Culture and Effectiveness
Synergies B2CConsistent above market growth is reinforced through the synergies between Rx and CHC sales across specific therapeutic areasNet sales per Therapeutic Area Rx vs CHC (2018, %)Top shared Rx & CHC ThAs:CardiologyGynecologyAlimentaryOphthalmologyTOP Rx and CHC target client synergies:CardiologyOphthalmologyDermatologyAlimentary
Go to market Therapeutic approach to customers aligning with customer objectives - moving from selling products to selling capabilities Emphasis on best in class capabilities– balanced strong local insights and regional scale Innovating with Digital and Traditional communication channels to customers to increase effectiveness Insight & continuous performance on key business drivers for each therapy/ Brand area Expertise in diversified Go to market models
Portfolio Pipeline aligned behind therapeutic Focus R&D model in strong collaboration with markets leveraging Customer + Patient insights to develop added value, improved Patient experience, combinations Therapeutic developments utilised as a platform for geographical expansion: expand the therapy areas we know how to win Local manufacturing enabling preferential market access Poland, Russia and Kazakhstan
Business Development Create excellence in therapeutic platforms to underpin Strategic Partnerships Therapeutic platform – partner of choice for new launches/ Brands with potential Partner with companies strong in a therapy in non covered markets Co-develop complimentary therapies License out services that we have developed to support brands
